2156 studies found for:    Lipid Storage Diseases
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM)
Condition: Neutral Lipid Storage Disease
Intervention: Drug: Fibrate treatment
2 Unknown  Genetic Origin of Lipid Disorders
Condition: Lipid Disorder
3 Recruiting Genes Involved in Lipid Disorders
Condition: Dyslipidemia
4 Recruiting Biomarker for Gaucher Disease
Conditions: Lysosomal Storage Diseases;   Gaucher Disease;   Sphingolipidoses
5 Recruiting LYSO-PROVE - Determine the Prognostic Value of Lyso-Gb1 for Monitoring the Progress of Gaucher Disease
Conditions: Lysosomal Storage Diseases;   Gaucher Disease;   Sphingolipidoses
6 Active, not recruiting A Mediterranean-style Breakfast and Postprandial Lipid Disorders in Obese Pre-adolescents and Adults
Condition: Obesity
Interventions: Dietary Supplement: Mediterranean-style breakfast;   Dietary Supplement: Western-style breakfast
7 Recruiting Natural History Study of Children With Metachromatic Leukodystrophy
Conditions: Leukodystrophy, Metachromatic;   Hereditary Central Nervous System Demyelinating Diseases;   Brain Diseases, Metabolic, Inborn;   Brain Diseases, Metabolic;   Brain Diseases;   Central Nervous System Diseases;   Nervous System Diseases;   Sulfatidosis;   Sphingolipidoses;   Lysosomal Storage Diseases, Nervous System;   Leukoencephalopathies;   Demyelinating Diseases;   Metabolism, Inborn Errors;   Genetic Diseases, Inborn;   Lipidoses;   Lipid Metabolism, Inborn Errors;   Lysosomal Storage Diseases;   Metabolic Diseases;   Lipid Metabolism Disorders
Intervention: Other: Natural History Study of Children With Metachromatic Leukodystrophy
8 Terminated A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers
Conditions: Obesity;   Lipid Disorders
Interventions: Drug: ZYT1;   Drug: Placebo tablets
9 Completed
Has Results
Lipid Management in Clinical Practice (MK-0524A-115)
Condition: Lipid Metabolism Disorder
10 Active, not recruiting Physical Activity and Nutrition in Children Study
Conditions: Overweight;   Glucose Metabolism Disorders;   Lipid Metabolism Disorders;   Blood Pressure
Intervention: Behavioral: lifestyle counseling
11 Terminated
Has Results
Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism
Conditions: Hurler's Syndrome;   Maroteaux-Lamy Syndrome;   Sly Syndrome;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Sphingolipidoses;   Krabbe Disease;   Wolman's Disease;   Niemann-Pick Disease Type B;   Niemann-Pick Disease, Type C
Interventions: Procedure: Stem Cell Transplantation;   Drug: Cyclophosphamide;   Drug: Campath-1H;   Drug: Busulfan
12 Recruiting MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis
Conditions: Mucopolysaccharidosis I;   Mucopolysaccharidosis II;   Mucopolysaccharidosis VI;   Mucopolysaccharidosis VII;   Hurler Syndrome;   Hunter Syndrome;   Maroteaux Lamy Syndrome;   Sly Syndrome;   Glycoprotein Metabolic Disorders;   Alpha Mannosidosis;   Fucosidosis;   Aspartylglucosaminuria;   Adrenoleukodystrophy;   Peroxisomal Disorders;   Osteopetrosis;   Sphingolipidosis;   Gangliosidosis;   Globoid Cell Leukodystrophy;   Metachromatic Leukodystrophy;   Niemann Pick B;   Niemann Pick C Subtype 2;   I-cell Disease
Interventions: Procedure: blood stem cell transplant;   Drug: Rabbit Anti-Thymocyte Globulin (ATG);   Drug: Fludarabine;   Drug: Busulfan;   Drug: Cyclophosphamide;   Drug: Cyclosporine A (CSA);   Drug: Methylprednisolone;   Drug: Mycophenolate Mofetil (MMF);   Drug: Granulocyte-Colony Stimulating Factor (G-CSF);   Drug: Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF);   Drug: N-acetylcysteine;   Drug: Celecoxib;   Drug: Vitamin E;   Drug: Alpha Lipoic Acid
13 Completed Pharmacological Regulation of Fat Transport in Metabolic Syndrome
Conditions: Obesity;   Lipid Disorders;   Hypertriglyceridemia;   Cardiovascular Disease
Intervention: Drug: Atorvastatin and fenofibrate
14 Enrolling by invitation The Very Large Database of Lipids (VLDL)
Condition: Lipid Disorders and Lipid Measurement
15 Active, not recruiting Identification of Novel Skeletal Muscle-derived Factors That Promote Lipid Oxidation (Columbus)
Conditions: Obesity;   Disorder of Lipid Storage and Metabolism;   Lipid Metabolism Disorders;   Metabolic Disorder
Intervention: Behavioral: Exercise
16 Recruiting Biomarker for Metachromatic Leukodystrophy Disease
Conditions: Leukodystrophy, Metachromatic;   Hereditary Central Nervous System Demyelinating Diseases;   Brain Diseases, Metabolic, Inborn;   Sphingolipidoses;   Lysosomal Storage Diseases, Nervous System
17 Recruiting A High-Resolution Magnetic Resonance Imaging Study to Evaluate the Effect of Rosuvastatin on Carotid Atherosclerotic Plaques
Conditions: Arteriosclerosis;   Diabetes Mellitus;   Lipid Disorder
Interventions: Drug: Rosuvastatin 5mg;   Drug: Rosuvastatin 20mg
18 Recruiting Familial Hypercholesterolemia Canada / Hypercholesterolemie Familiale Canada
Conditions: Familial Hypercholesterolemia;   Lipid Disorder
19 Active, not recruiting Effect of Age on Glucose and Lipid Metabolism
Conditions: Glucose Metabolism Disorders;   Lipid Metabolism Disorders;   Metabolic Diseases
Intervention: Behavioral: Aerobic Exercise
20 Recruiting Metabolic Complications Following Knee Injury in Young and Middle Aged Patients
Conditions: Glucose Metabolism Disorders;   Lipid Metabolism Disorders;   Sedentary Lifestyle
Interventions: Biological: Blood and Urine sampling;   Radiation: DXA scan;   Biological: OGTT

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years